|
PUS7 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.76199951798617E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.441400E-04 |
| Normal-vs-Stage2 |
3.028400E-02 |
| Normal-vs-Stage3 |
2.116700E-03 |
| Normal-vs-Stage4 |
6.007400E-04 |
| Stage1-vs-Stage2 |
6.617800E-01 |
| Stage1-vs-Stage3 |
6.725700E-02 |
| Stage1-vs-Stage4 |
8.59459999946743E-07 |
| Stage2-vs-Stage3 |
2.434800E-01 |
| Stage2-vs-Stage4 |
5.565600E-04 |
| Stage3-vs-Stage4 |
2.504300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.45819999969521E-07 |
| Normal-vs-AfricanAmerican |
2.758000E-04 |
| Normal-vs-Asian |
1.621640E-02 |
| Caucasian-vs-AfricanAmerican |
3.917800E-01 |
| Caucasian-vs-Asian |
2.260000E-01 |
| AfricanAmerican-vs-Asian |
4.037400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.36529999997348E-06 |
| Normal-vs-Female |
1.49480000044555E-07 |
| Male-vs-Female |
1.763850E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.162890E-03 |
| Normal-vs-Extreme_Weight |
6.179100E-03 |
| Normal-vs-Obese |
6.807700E-04 |
| Normal-vs-Extreme_Obese |
4.327000E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.542200E-02 |
| Normal_Weight-vs-Obese |
5.283400E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.538000E-01 |
| Extreme_Weight-vs-Obese |
9.508500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.354200E-01 |
| Obese-vs-Extreme_Obese |
3.715000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.124600E-03 |
| Normal-vs-Age(41-60Yrs) |
4.22839999680846E-08 |
| Normal-vs-Age(61-80Yrs) |
9.392600E-04 |
| Normal-vs-Age(81-100Yrs) |
2.880200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.763700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.387940E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.264000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.076280E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.823200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.491800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.0284999996113E-07 |
| Normal-VS-Type2 PRCC |
1.849820E-02 |
| Normal-VS-KIRP CIMP |
5.236600E-03 |
| Normal-VS-Unclassified PRCC |
9.780100E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.299800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.818410E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.631600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.246300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.533200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.099500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.456300E-02 |
| Normal-vs-N1 |
3.358900E-04 |
| Normal-vs-N2 |
7.274500E-02 |
| N0-vs-N1 |
2.456300E-03 |
| N0-vs-N2 |
1.883360E-01 |
| N1-vs-N2 |
4.571400E-01 |
|
|
